Cargando…
MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis
Upregulation of MYC and miRNAs deregulation are common in prostate cancer (PCa). Overactive MYC may cause miRNAs’ expression deregulation through transcriptional and post-transcriptional mechanisms and epigenetic alterations are also involved in miRNAs dysregulation. Herein, we aimed to elucidate th...
Autores principales: | Barros-Silva, Daniela, Costa-Pinheiro, Pedro, Duarte, Henrique, Sousa, Elsa Joana, Evangelista, Adriane Feijó, Graça, Inês, Carneiro, Isa, Martins, Ana Teresa, Oliveira, Jorge, Carvalho, André L., Marques, Márcia M., Henrique, Rui, Jerónimo, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833437/ https://www.ncbi.nlm.nih.gov/pubmed/29415999 http://dx.doi.org/10.1038/s41419-017-0241-y |
Ejemplares similares
-
SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
por: Vieira, Filipa Quintela, et al.
Publicado: (2015) -
Anti-neoplastic properties of hydralazine in prostate cancer
por: Graça, Inês, et al.
Publicado: (2014) -
Targeting DNA Methyltranferases in Urological Tumors
por: Marques-Magalhães, Ângela, et al.
Publicado: (2018) -
Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer
por: Baptista, Tiago, et al.
Publicado: (2013) -
Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype
por: Vieira-Silva, Tânia Soraia, et al.
Publicado: (2019)